KAYALOGY.ch

AI-Based Early Multi-Cancer Detection

From Early Detection to Global Impact – Kayalogy’s AI is redefining how the world fights cancer.
Kayalogy is developing a breakthrough AI-powered diagnostic platform for the earliest possible detection of cancer – launching with our near-market breast cancer model and expanding to 18 additional cancer types.

Near-Market AI Precision: Trained on trillions of medical voxels and clinically validated, our breast cancer AI is engineered for unmatched, real-world accuracy.

Fully Web-Based & Scalable: A 100% privacy-compliant SaaS solution requiring no additional hardware, integrating seamlessly into clinical workflows, and instantly scalable worldwide.

Our Core Mission: Deliver the world’s most precise, earliest, and easiest-to-deploy AI cancer detection – saving lives across the globe.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No news

No milestones

No Jobs

No videos and documents

No Awards

KAYALOGY.ch

AI-Based Early Multi-Cancer Detection

Headquarter:
Zürich

Foundation Date:
April 2025

Technology:

  • Biotech

Sectors:

  • Cancer
  • Diagnostics
  • Machine Learning / AI
  • Medtech
  • Software